Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 13962-13964 [2019-06846]
Download as PDF
<![CDATA[
13962
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 8, 2019. Such persons
may also file a written request for a
hearing on the application on or before
May 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
DATES:
In accordance with 21 CFR
1301.34(a), this is notice that on
February 4, 2019, Unither
Manufacturing LLC, 331 Clay Road,
Rochester, New York 14623–3226
applied to be registered as an importer
of the following basic class of controlled
substance:
Controlled
substance
Drug code
Methylphenidate ...
1724
Schedule
II
The company plans to import the
listed substance solely for updated
analytical testing purposes for EU
customer requirements. This analysis is
required to allow the company to export
domestically-manufactured finished
dosage forms to foreign markets.
Approval of permit applications will
occur only when the registrant’s activity
is consistent with what is authorized
under to 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–06850 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Synthcon,
LLC
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 7, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 1, 2019, Synthcon, LLC, 770
Wooten Road, Unit 101, Colorado
Springs, Colorado 80915 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Notice of application.
jbell on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
Amphetamine .......................................................................................................................................................................
Methamphetamine ................................................................................................................................................................
3-Fluoro-N-methylcathinone (3-FMC) ...................................................................................................................................
Cathinone .............................................................................................................................................................................
Methcathinone ......................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ...................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) .........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) .....................................................................................................................................
Naphyrone ............................................................................................................................................................................
N-Ethylamphetamine ............................................................................................................................................................
N,N-Dimethylamphetamine ..................................................................................................................................................
Aminorex ..............................................................................................................................................................................
4-Methylaminorex (cis isomer) .............................................................................................................................................
Gamma Hydroxybutyric Acid ................................................................................................................................................
Methaqualone .......................................................................................................................................................................
Mecloqualone .......................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ........................................................................................................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .......................................
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) .............................................................................................................................
VerDate Sep<11>2014
17:45 Apr 05, 2019
Jkt 247001
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
E:\FR\FM\08APN1.SGM
08APN1
1100
1105
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1585
1590
2010
2565
2572
6250
7035
7118
7173
Schedule
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
13963
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
jbell on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...........................................................................................................
Alpha-ethyltryptamine ...........................................................................................................................................................
Ibogaine ................................................................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................
Lysergic acid diethylamide ...................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) .....................................................................................................
Tetrahydrocannabinols .........................................................................................................................................................
Mescaline .............................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) .................................................................................................
3,4,5-Trimethoxyamphetamine .............................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ...............................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................................
2,5-Dimethoxyamphetamine .................................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...........................................................................................................
2,5-Dimethoxy-4-ethylamphetamine .....................................................................................................................................
3,4-Methylenedioxyamphetamine .........................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................
3,4-Methylenedioxymethamphetamine .................................................................................................................................
4-Methoxyamphetamine .......................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................................
Alpha-methyltryptamine ........................................................................................................................................................
Bufotenine ............................................................................................................................................................................
Diethyltryptamine ..................................................................................................................................................................
Dimethyltryptamine ...............................................................................................................................................................
Psilocybin .............................................................................................................................................................................
Psilocyn ................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine .........................................................................................................................................
1-Phenylcyclohexylamine .....................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................................
Phencyclidine .......................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................................
N-Ethyl-3-piperidyl benzilate ................................................................................................................................................
N-Methyl-3-piperidyl benzilate ..............................................................................................................................................
N-Benzylpiperazine ..............................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..........................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) .......................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) .........................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ......................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) .............................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ........................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) ..........................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ...................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) .........................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) ..........................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ..........................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ...............................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ...........................................................................................................
Butylone ................................................................................................................................................................................
Pentylone ..............................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) .............................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ...............................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .........................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ..........................................................................................................................
Phenylacetone ......................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile .....................................................................................................................................
Alphaprodine ........................................................................................................................................................................
Anileridine .............................................................................................................................................................................
Cocaine ................................................................................................................................................................................
Etorphine (except HCl) .........................................................................................................................................................
Diphenoxylate .......................................................................................................................................................................
Ecgonine ...............................................................................................................................................................................
Heroin ...................................................................................................................................................................................
Levorphanol ..........................................................................................................................................................................
Meperidine ............................................................................................................................................................................
Meperidine intermediate–A ..................................................................................................................................................
Meperidine intermediate–B ..................................................................................................................................................
VerDate Sep<11>2014
17:45 Apr 05, 2019
Jkt 247001
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
E:\FR\FM\08APN1.SGM
08APN1
7200
7203
7249
7260
7297
7298
7315
7348
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7460
7470
7471
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
8333
8501
8603
9010
9020
9041
9056
9170
9180
9200
9220
9230
9232
9233
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
I
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
I
II
II
I
II
II
II
II
13964
Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices
Controlled substance
Drug code
Meperidine intermediate–C ..................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................................
Morphine ...............................................................................................................................................................................
Normorphine .........................................................................................................................................................................
Acetorphine ..........................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ....................................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide)) ......................................................................
Acetylmethadol .....................................................................................................................................................................
Allylprodine ...........................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..........................................................................................................
Alphameprodine ...................................................................................................................................................................
Alphamethadol ......................................................................................................................................................................
Benzethidine .........................................................................................................................................................................
Betacetylmethadol ................................................................................................................................................................
Clonitazene ...........................................................................................................................................................................
Diampromide ........................................................................................................................................................................
Diethylthiambutene ...............................................................................................................................................................
Dimethylthiambutene ............................................................................................................................................................
Ketobemidone ......................................................................................................................................................................
Levo-alphacetylmethadol ......................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ...........................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ...................................................................................................................
Alfentanil ...............................................................................................................................................................................
Remifentanil ..........................................................................................................................................................................
Sufentanil ..............................................................................................................................................................................
Carfentanil ............................................................................................................................................................................
Tilidine ..................................................................................................................................................................................
Tapentadol ............................................................................................................................................................................
Fentanyl ................................................................................................................................................................................
Para-Fluorofentanyl ..............................................................................................................................................................
3-Methylfentanyl ...................................................................................................................................................................
Alpha-methylfentanyl ............................................................................................................................................................
Acetyl-alpha-methylfentanyl .................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................................
Beta-hydroxyfentanyl ............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl .............................................................................................................................................
Alpha-methylthiofentanyl ......................................................................................................................................................
3-Methylthiofentanyl .............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................................
Thiofentanyl ..........................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ...............................................................................
Cyclopropyl Fentanyl ............................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ........................................................................................
The company plans to manufacture
the above-listed controlled substances
as analytical reference standards for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–06846 Filed 4–5–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
jbell on DSK30RV082PROD with NOTICES
Office of Federal Contract Compliance
Programs
Construction Compliance Check
Letters; New Information Collection
Requirements; Comment Request
ACTION:
Notice.
VerDate Sep<11>2014
17:45 Apr 05, 2019
Jkt 247001
The Department of Labor
(DOL), as part of its continuing effort to
reduce paperwork and respondent
burden, conducts a pre-clearance
consultation program to provide the
general public and federal agencies with
an opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995
(PRA). The program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the Office
of Federal Contract Compliance
Programs (OFCCP) is soliciting
comments concerning its proposal to
obtain approval from the Office of
Management and Budget (OMB) to
implement the Construction
Compliance Check Letters. A copy of
SUMMARY:
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
9234
9273
9300
9313
9319
9547
9551
9601
9602
9603
9604
9605
9606
9607
9612
9615
9616
9619
9628
9648
9661
9663
9737
9739
9740
9743
9750
9780
9801
9812
9813
9814
9815
9821
9830
9831
9832
9833
9834
9835
9843
9845
9850
Schedule
II
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
I
I
II
II
II
II
I
II
II
I
I
I
I
I
I
I
I
I
I
I
I
I
I
the proposed information collection
request can be obtained by contacting
the office listed below in the FOR
FURTHER INFORMATION CONTACT section of
this Notice or by accessing it at
www.regulations.gov.
Written comments must be
submitted to the office listed in the
addresses section below on or before
June 7, 2019.
DATES:
You may submit comments
by any of the following methods:
Electronic comments: The federal
eRulemaking portal at
www.regulations.gov. Follow the
instructions found on that website for
submitting comments.
Mail, Hand Delivery, Courier:
Addressed to Harvey D. Fort, Acting
Director, Division of Policy and Program
Development, Office of Federal Contract
Compliance Programs, 200 Constitution
Avenue NW, Room C–3325,
Washington, DC 20210.
ADDRESSES:
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13962-13964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06846]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Synthcon,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before June 7, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
February 1, 2019, Synthcon, LLC, 770 Wooten Road, Unit 101, Colorado
Springs, Colorado 80915 applied to be registered as a bulk manufacturer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amphetamine.......................... 1100 II
Methamphetamine...................... 1105 II
3-Fluoro-N-methylcathinone (3-FMC)... 1233 I
Cathinone............................ 1235 I
Methcathinone........................ 1237 I
4-Fluoro-N-methylcathinone (4-FMC)... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).... 1249 I
Naphyrone............................ 1258 I
N-Ethylamphetamine................... 1475 I
N,N-Dimethylamphetamine.............. 1480 I
Aminorex............................. 1585 I
4-Methylaminorex (cis isomer)........ 1590 I
Gamma Hydroxybutyric Acid............ 2010 I
Methaqualone......................... 2565 I
Mecloqualone......................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-
3-carboxamide).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
[[Page 13963]]
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I
(1-naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
Alpha-ethyltryptamine................ 7249 I
Ibogaine............................. 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide........... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Tetrahydrocannabinols................ 7370 I
Mescaline............................ 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine.......... 7390 I
4-Bromo-2,5-dimethoxyamphetamine..... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine.. 7392 I
4-Methyl-2,5-dimethoxyamphetamine.... 7395 I
2,5-Dimethoxyamphetamine............. 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine..... 7399 I
3,4-Methylenedioxyamphetamine........ 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N-ethylamphetamine 7404 I
3,4-Methylenedioxymethamphetamine.... 7405 I
4-Methoxyamphetamine................. 7411 I
5-Methoxy-N-N-dimethyltryptamine..... 7431 I
Alpha-methyltryptamine............... 7432 I
Bufotenine........................... 7433 I
Diethyltryptamine.................... 7434 I
Dimethyltryptamine................... 7435 I
Psilocybin........................... 7437 I
Psilocyn............................. 7438 I
5-Methoxy-N,N-diisopropyltryptamine.. 7439 I
N-Ethyl-1-phenylcyclohexylamine...... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.... 7458 I
1-Phenylcyclohexylamine.............. 7460 II
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
Phencyclidine........................ 7471 II
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate........ 7482 I
N-Methyl-3-piperidyl benzilate....... 7484 I
N-Benzylpiperazine................... 7493 I
4-Methyl- 7498 I
alphapyrrolidinopropiophenone (4-
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine 7517 I
(2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-T-4
).
MDPV (3,4-Methylenedioxypyrovalerone) 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-
NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-
NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-
NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone............................. 7541 I
Pentylone............................ 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone........................ 8501 II
1-Piperidinocyclohexanecarbonitrile.. 8603 II
Alphaprodine......................... 9010 II
Anileridine.......................... 9020 II
Cocaine.............................. 9041 II
Etorphine (except HCl)............... 9056 I
Diphenoxylate........................ 9170 II
Ecgonine............................. 9180 II
Heroin............................... 9200 I
Levorphanol.......................... 9220 II
Meperidine........................... 9230 II
Meperidine intermediate-A............ 9232 II
Meperidine intermediate-B............ 9233 II
[[Page 13964]]
Meperidine intermediate-C............ 9234 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine............................. 9300 II
Normorphine.......................... 9313 I
Acetorphine.......................... 9319 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)
cyclohexylmethyl]benzamide)).
Acetylmethadol....................... 9601 I
Allylprodine......................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine....................... 9604 I
Alphamethadol........................ 9605 I
Benzethidine......................... 9606 I
Betacetylmethadol.................... 9607 I
Clonitazene.......................... 9612 I
Diampromide.......................... 9615 I
Diethylthiambutene................... 9616 I
Dimethylthiambutene.................. 9619 I
Ketobemidone......................... 9628 I
Levo-alphacetylmethadol.............. 9648 II
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Alfentanil........................... 9737 II
Remifentanil......................... 9739 II
Sufentanil........................... 9740 II
Carfentanil.......................... 9743 II
Tilidine............................. 9750 I
Tapentadol........................... 9780 II
Fentanyl............................. 9801 II
Para-Fluorofentanyl.................. 9812 I
3-Methylfentanyl..................... 9813 I
Alpha-methylfentanyl................. 9814 I
Acetyl-alpha-methylfentanyl.......... 9815 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Beta-hydroxyfentanyl................. 9830 I
Beta-hydroxy-3-methylfentanyl........ 9831 I
Alpha-methylthiofentanyl............. 9832 I
3-Methylthiofentanyl................. 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl......................... 9835 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Cyclopropyl Fentanyl................. 9845 I
Fentanyl related-compounds as defined 9850 I
in 21 CFR 1308.11&h).
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances as analytical reference standards for distribution to its
customers. No other activities for these drug codes are authorized for
this registration.
Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06846 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P
